Updated:
LifeSci Venture Partners
LifeSci Venture Partners provides collaborative capital that accelerates medical breakthroughs. The firm applies collective clinical, scientific and...
Overview
LifeSci Venture Partners provides collaborative capital that accelerates medical breakthroughs. The firm applies collective clinical, scientific and investment expertise to drive long-term conviction in portfolio companies. It seeks companies that aim to reshape medical care through novel approaches to molecular medicine, technology or healthcare delivery, partners with entrepreneurs, clinicians and scientists, and targets clinical-stage opportunities that have achieved proof-of-concept and plan to transition to the public market within 12-18 months. Portfolio companies also receive support through affiliate LifeSci Partners, a healthcare consultancy.
General information
Firm type
Venture Capital
Location
Region
North America
Country
United States
City
New York
Principals
Paul Yook
Managing Partner & CIO
Ryan Cinalli
Ph.D., Partner & CSO
Ira Kalfus
M.D., Venture Partner
Brittany Amendola
C.P.A., Chief Financial Officer
Jeff Seo
Business Development
Sector focus
Frequently asked questions
Who runs investment decisions at LIFESCI VENTURE MANAGEMENT?
The firm's leadership and investment committee composition are not documented in the public record. This level of privacy is not unusual for specialized life sciences vehicles, where scientific advisory networks and venture partners often hold significant influence over investment decisions alongside named principals.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: